China s CapitalBio to Enter Global Microarray Tools Market with LuxScan Scanner Launch | GenomeWeb

San Diego — CapitalBio, a Chinese biotech tools company, will launch its first microarray-related product in the North American, European, and Asian markets this year, according to Weiping Yang, the company’s senior vice president of proteomics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.